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Background: Linker for activation of T cells (LAT), a transmembrane adaptor protein, plays a role in T cell and mast
cell function, while it remains unclear how histone modifications mediate LAT expression in allergic asthma. The
present study aimed at understanding alterations of lymphocyte LAT in patients with asthma and potential
mechanisms by which histone modulation may be involved in.
Method: The expression of LAT mRNA was checked by Quantitative real-time PCR and histone hypoacetylation on
LAT promoter was detected by Chromatin Immunoprecipitation.
Results: Our results demonstrated that the expression of LAT mRNA in peripheral blood T cells from patients with
asthma decreased, as compared to healthy controls. Peripheral blood T cells were treated with pCMV-myc-LAT,
pCMV-myc or LAT-siRNA plasmid. Over-expression of LAT mRNA and decrease of Th2 cytokine production were
noted, which could be prevented by the inhibition of LAT. The further investigation of the role of histone was
performed in an asthma model induced by allergen. Histone hypoacetylation on LAT promoter could inhibit LAT
expression and enhanced Th2 differentiation, while trichostatin A, a histone deacetylase inhibitor, promoted LAT
expression and inhibited Th2 cytokine production.
Conclusion: Our results indicate that histone hypoacetylation may regulate LAT expression on T cells and modify
Th2 polarization in allergic asthma.
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Linker for activation of T cells (LAT) is a transmembrane
protein, which is expressed in thymocytes, mature T cells,
NK cells, mast cells, megakaryocytes, and pre-B cells [1-4].
As lacking any intrinsic enzymatic activity, the ability of
LAT to transmit signals depends upon its phosphorylation.
Upon TCR engagement, phosphorylation of LAT allows it
to interact with several SH2 domain-containing proteins,
such as Grb2 and PLC-γ1. LAT serves to nucleate a large
signaling complex upon TCR engagement that is essential
for T-cell development and function [5]. It has been shown
that mice homozygous for a single tyrosine mutation in
LAT exhibited an early block in T cell maturation but later* Correspondence: guoxjz@yahoo.com.cn
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reproduction in any medium, provided the ordeveloped a polyclonal lymphoproliferative disorder that
produced high amounts of Th2 cytokines. This exagger-
ated Th2 differentiation caused tissue eosinophilia and
massive maturation of plasma cells secreting to immuno-
globulins of the E and G1 isotypes [6,7]. These data suggest
that LAT is crucial in regulating Th2 polarization.
Allergic asthma is a common health problem, which is
characterized by chronic airway inflammation associated
with a T helper (Th) 2 immune response to environment
allergens [8,9]. However, whether LAT is involved in the
pathogenesis of allergic asthma has not been clearly
identified.
Modifications of core histones, including acetylation,
methylation, phosphorylation and ubiquitination, play
a critical role in alteration of chromatin structure
and gene transcription [10]. Among those modifica-
tions, acetylation and methylation of histone lysine
residue have been well characterized [11]. Histonehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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decondensation, allowing transcription activators access
to DNA and increasing transcriptional activity, whereas
histone hypoacetylation is linked with chromatin con-
densation and transcriptional repression [12,13]. It has
been shown that the acetylation of histones is regulated
by histone deacetylases (HDACs) [14]. Moreover, lysine
methylation can exist in three different states, mono-
methylated (me1), dimethylated (me2), and trimethylated
(me3). Generally, transcriptionally silent regions contain
H3K9me3 (trimethyl), H3K27me2/3 (di- and trimethyl),
and H4K20me1 (monomethyl), whereas active genes cor-
relate with H3K4me2/3 (di- and trimethyl), H3K36me2/3
(di- and trimethyl), and H3K79me2 (dimethyl) [15-17].
However, the function of histone modification in LAT
expression in allergic asthma has not been addressed.
In this study, we found that LAT expression was
significantly decreased in T cells from asthmatic patients.
Overexpression of LAT in T cells resulted in impaired
Th2 polarization, whereas LAT deficiency enhanced Th2
cell development. In an allergen-induced asthma model,
histone hypoacetylation on LAT promoter inhibited
LAT expression and enhanced Th2 differentiation. In
contrast, Trichostatin A (TSA), a histone deacetylase in-
hibitor, promoted LAT expression and attenuated Th2
cytokine production. Our results thus indicate that LAT,
regulated by histone modification, is an essential regula-
tor in Th2 polarization in allergic asthma.
Materials and methods
Human study subjects
Study participants were randomly selected from outpati-
ents and inpatients of Xinhua Hospital, Shanghai Jiao
Tong University. Twenty participants with allergic asthma
(10 women, 10 men) and twenty participants (10 women,
10 men) were healthy controls. Asthma was diagnosed
from common symptoms and pulmonary functions [18].
The severity of asthma was evaluated on the basis of the
Global Initiative for Asthma criteria [19], both mild and
moderate asthmatics were enrolled. The skin-prick test
(SPT) was performed using a standard panel of 11 aller-
gens, a 15 mm diameter skin wheal response was defined
as positive. In the four weeks prior to the study, asthmatic
participants were permitted to be treated with inhaled
glucocorticoid but not systemic steroids.
The healthy control subjects with age and sex matched to
allergic asthma participants were reported no allergic dis-
eases, were negative SPTand had not received oral or intra-
venous steroids in the previous 4 weeks before the study.
All subjects were fully informed about the purpose
and nature of the studies, which were approved by the
medical ethics committee of Xinhua Hospital. Written
informed consent was obtained from the patients for
publication of this report and any accompanying images.Peripheral blood T lymphocytes
Isolation and purification
Twenty milliliters of fresh human peripheral blood was
obtained from allergic asthmatics and healthy controls.
Peripheral blood mononuclear cells (PBMCs) were iso-
lated by density gradient centrifugation using Lympho-
prep (d = 1.077 mg/ml; Nycomed Pharma AS, Roskide,
Denmark). The purified blood T cells were subsequently
obtained using T Cell Negative Isolation Kit (Invitrogen
Dynal AS, Oslo, Norway) according to the manufac-
turer’s instruction. The purity of T cells was 90-95%.
Nucleofection
The purified peripheral blood T cells were nucleofected
with pCMV-myc-LAT, pCMV-myc or LAT-siRNA plas-
mids (nucleofect with three kinds of plasmids in healthy
controls and pCMV-myc-LAT, pCMV-myc plasmids in
asthma patients) using the Human T Cell NucleofectorW
Kit (Amaxa, Lonza, Germany). The protocol was done
according to the manufacturer’s instruction.
Activation
The nucleofected T cells were activated with anti-CD3
(1 μg/ml, BD Bioscience) and anti-CD28 (1 μg/ml, BD
Bioscience) and cultured for 24 h at 37°C with 5% CO2.
Cells were harvested for Western Blot analysis and the
supernatants were collected and preserved at −20°C for
ELISA.
Animal study
Male, 6-8-week-old Wistar rats from Sinobritish Sipprbk
Lab Animal Ltd (Shanghai, China) were maintained
under pathogen-free conditions at the animal center of
Xinhua Hospital, Shanghai and were age- and sex-
matched within each experiment. Mice studies were
approved by the Xinhua Hospital Animal Care and Use
Committee.
Sensitization and airway challenge
Wistar rats were sensitized twice, with an interval of
7 days, by the intraperitoneal (i.p) injection of 0.5 ml of
2 mg chicken ovalbumin (OVA) (Grade V, Sigma-
Aldrich, shanghai, china) bound to 200 mg aluminum
hydroxide Al(OH)3 (Sigma) in saline. Simultaneously,
6 × 109 heat-killed Bordetella pertussis bacilli were admi-
nistered intraperitoneally as an adjuvant. From day 15 to
day 28, rats were exposed to aerosolized OVA (1% in
saline) or saline alone (Control groups) for 20 minutes
once a day. The aerosol was generated with a nebulizer
(PARIBOY N037, PARI, Starnberg, Germany) and was
drawn into the exposure chamber containing the awake
animals. Rats were euthanized (50 mg/kg pentobarbital,
i.p.) 24 h after the final challenge, serum, bronchoalveo-
lar lavage fluid (BALF) and lungs were sampled.
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Lung lymphocytes were acquired by Lymphocytes Separ-
ation Medium (HISTOPAQUE 1083, Sigma, St. Louis,
MO, USA). T lymphocytes were purified from mono-
nuclear cells by nylon wool filtration. The purity of T
cells was > 85%, as assessed by flow cytometry with anti-
CD3-FITC antibody (eBioscience, San Diego, CA, USA).
The purified lung T cells were incubated with or without
TSA (2.5 ng/ml) for 24 h. After incubation, the superna-
tants were collected, pooled per stimulation for cytokine
production analysis, and cells were harvested for either
total protein and RNA isolation or ChIP assay.
Cytokine measurement
The level of rats IL-4 and IFN-γ in BALFs and serum of
immunized and non-immunized rats, and in the super-
natants of cultured lung T cells with or without TSA
were measured and quantified by ELISA following the
manufacturer’s instructions (ELISA kit, invitrogen). As
well as the production of IL-4 and IFN-γ in the human
peripheral blood nucleofected T cells from allergic asth-
matics and healthy controls.
Quantitative real-time PCR
Total RNA in human peripheral blood T cells and rat lung
T cells was extracted using TRIzol reagent (invitrogen)
and 1 μg of RNA was reversed transcripted using cDNA
synthesis kit (TaKaRa, Dalian, China). The primer specific
for LAT (forward, 5’-GAGGATGTGGATGGAGAGGA-
3’; reverse, 5’-CTGTAGGCA AGGCAGAGGTC-3’, which
produced a 143 bp product) and GAPDH (forward, 5’-
GCAAGTTCAACGGCACAG-3’; reverse, 5’-GCCAGTA
GACTCCACGACAT-3’, which produced a 140 bp prod-
uct), were designed and synthesized by Beyotime Institute
of Biotechnology, Shanghai, China.
The quantitative real-time PCR was performed on an
ABI PRISM 7500 Fast Real-Time PCR System (ABI,
USA), and SYBR Green (TaKaRa, Dalian, China) was
used as a double-stranded DNA-specific fluorescent dye.
GAPDH was used as a housekeeping gene for standard-
izing LAT mRNA expression. After normalization of the
data according to the expression of β-actin mRNA, rela-
tive levels of LAT and GAPDH were calculated using the
2—△△Ct method [20].
Western immunoblotting
Lung T cell and human nucleofected T cell protein
extracts were prepared. Approximately 20–30 μg of pro-
tein was subjected to 10% SDS/PAGE gels and trans-
ferred to polyvinylidene difluoride membranes (Millipore
Corporation, Billerica, MA, USA). After transfer, the
membranes were blocked by 5% fat-free milk in TBST
(20 mM Tris–HCl pH 7.6, 137 mM NaCl, 0.1% Tween-20)
for 1 h at room temperature (RT) and incubated withprimary antibodies against LAT (1:750) (Cell Signal),
HDAC1 (1:750) (Cell Signal, Danvers, MA, USA),
acetyl-H3 (1:20000) (Millipore Corporation), acety-H4
(1:2000) (Millipore Corporation) or dimethyl-H3K9
(1:500) (Millipore Corporation) overnight at 4°C in the
TBST, and then incubated with an HRP-labeled second-
ary antibody (1:1000) (Beyotime Institute of Biotechnol-
ogy, Shanghai, china) for 2 h at RT. Incubation with
anti-GAPDH (1:1500) (Abcam, San Francisco, CA
94105, USA) served as a loading control. The blots were
visualized by chemiluminescence with ECL Western blot-
ting detection reagents (Millipore Corporation).
ChIP Assay
The ChIP assay was carried out using a ChIP assay kit
(Millipore) according to the manufacturer’s protocol with
minor modification. Cultured lung T cells (~8 × 106) were
cross-linked by 0.4% formaldehyde at 37°C for 5 min, and
then excess formaldehyde was quenched by addition of
glycine at a final concentration of 0.125 M. Sonication
was performed on ice using a Bioruptor sonicator to
shear the cross-linked DNA to an average length of
200–1000 bp. Supernatants of the samples were col-
lected and diluted 10 fold in ChIP dilution buffer (20 μl
of each was reserved as total input control) followed
with preimmunoprecipitation clearing with 80 μl of a
Protein A Agarose/Salmon Sperm DNA −50% Slurry
for 30 minutes at 4°C with agitation. Immunoprecipita-
tion was performed with 4 μl of anti-acetylhistone H3,
anti-acetylhistone H4 anti-acetylhistone H3 or anti-
dimethylhistone H3 (K9) and incubated overnight at 4°C
with rotation. Immune complexes were collected with
60 μl protein A agarose/salmon sperm DNA for 60 min
at 4°C with rotation and washed twice with low salt
buffer, once with high salt buffer, once with LiCl buffer,
and twice with TE Buffer. The immune complexes were
eluted twice from the antibody by with 250 ul elution
buffer. The elutes and the input were heated at 65°C
for 6 h to reverse histone-DNA croosslinks by the
addition of 20 μl of 5 M NaCl. DNA was extracted
using a DNA Mini Preparation Kit (Beyotime Institute
of Biotechnology, Shanghai, china). 2 μl of each of the
purified DNA was used as template for 32 cycles of
PCR amplification. The PCR products were analyzed
on 1.5% agarose gel. The following primers of rat LAT
gene, covering the 5’-flanking region (−75/+23), were
used: 5’-TGAGGAGCCTGATGATTTCC-3’; 5’-GCTG
TACCTGCCTTTCTTGC-3’. Non-specific IgG (Beyotime
Institute of Biotechnology, Shanghai, China) was served as
the negative control in the assay.
Statistical analysis
All data were expressed as mean ± SD. Differences be-
tween groups were calculated for statistical significance
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ered as statistically significant.
Results
LAT mRNA was decreased in peripheral blood T cells from
allergic asthmatic patients
To determine the role of LAT in allergic asthma, the LAT
mRNA expression on peripheral blood T cells from aller-
gic asthmatic patients and healthy controls was evaluated.
The relative LAT mRNA level was dramatically decreased
in the peripheral blood T cells from allergic asthmatic
patients compared to healthy controls (Figure 1A-B,
P < 0.01), emphasizing the role of LAT in allergic asthma.
LAT regulates the differentiation of peripheral blood
T cells in vitro
To clarify whether LAT can regulate human peripheral
blood T cells differentiation in allergic asthma, Cytokine
production was tested in vitro. After necleofection with
pCMV-myc-LAT, pCMV-myc or LAT-siRNA plasmids
into peripheral blood T cells, the expression of LAT pro-
tein was higher in allergic asthmatic patients compared to
healthy controls (Figure 2A). Twenty-four hours stimula-
tion of nucleofected T cells was used to investigate the
production of IL-4 and IFN-γ, which representing Th2
and Th1 differentiation. IL-4 production was significantly
reduced in peripheral blood T cells with overexpression of
LAT (pCMV-myc-LAT) compared to control (pCMV-
myc) in both healthy controls and asthmatic patients,
while IFN-γ production was increased. Conversely, LAT
deficient (LAT-siRNA) displayed increased IL-4 expres-
sion and decreased IFN-γ expression in healthy controls
(Figure 2B). The results confirmed that LAT can be a cru-
cial factor regulating human T cell differentiation in vitro.
Histone hypoacetylation inhibits LAT transcription
To further determine the mechanism that T cell differ-
entiation was regulated by LAT expression, an OVAFigure 1 Expression of LAT mRNA in peripheral blood T cells in asthm
was determined by real-time PCR in peripheral blood T cells from asthmati
ratio of LAT/β-actin was determined as the relative content of LAT mRNA.
analysis of LAT expression in asthmatic patients and healthy controls.immunized allergic airway inflammation rat model was
applied. Consistent with the results in peripheral blood
T cells from allergic asthmatic patients, both LAT
mRNA (Figure 3A) and protein (Figure 3B-C) were
greatly decreased in lung T cells in immunized rats com-
pared to non-immunized ones.
To detect whether histone modifications were involved
in regulating LAT expression in allergic asthma, the pro-
tein level of histones was measured in lung T cells in
immunized rats and non-immunized ones. There was no
significant different pattern in the expression of whole
histone H3 and H4 acetylation and whole H3K9
dimethylation in lung T cells between immunized rats
and non-immunized ones. However, the expression of
HDAC1 was significantly decreased in lung T cells from
immunized rats compared to non-immunized ones
(Figure 3D-E).
To further illuminate whether histone modifications
regulate LAT expression is directly or indirectly. Acetyl-
ation levels of histone H3 and H4 and dimethylation
level of H3K9 at LAT upstream region was detected.
CHIP analysis revealed that the acetylation level of his-
tone H3 and H4 was markedly decreased and dimethyla-
tion level of H3K9 was dramatically increased in
immunized rats compared to non-immunized ones
(Figure 3F-G). These results indicate that lower expres-
sion of LAT in allergic airway inflammation may be
regulated by decreased histone H3 and H4 acetylation
and increased histone H3K9 dimethylation.
TSA reverses the function of histone hypoacetylation and
cytokine profiles in T cell differentiation in vitro
Previous result showed that HDAC1 was largely reduced
after OVA exposure, emphasizing the role of HDAC1 in
allergic airway inflammation. TSA physically binds to
HDAC molecules, which results in HDAC inhibition
[21,22]. Therefore, it was hypothesized that TSA can
regulate LAT transcription and expression by inhibitingatic patients and healthy controls. A) The mRNA expression of LAT
c patients and healthy controls, which was normalized to β-actin. The
Data is shown as mean ± SD, n = 10 (*p < 0.05). B) Image of RT-PCR
Figure 2 Overexpression of LAT inhibits Th2 cytokine production and promoted Th1 cytokine production in human peripheral blood
T cells in both asthmatic patients and healthy controls. Purified peripheral blood T cells from allergic asthmatic patients and healthy controls
were nucleofected with pCMV-myc-LAT, pCMV-myc, LAT-siRNA plasmids separately. A) LAT expression was analyzed by western blot.
B) Nucleofected T cells were activated with anti-CD3 and anti-CD28 for 24 h. Cytokine production of IL-4 and IFN-γ was measured by ELISA. Data
is shown as mean ± SD, n = 10 (*p < 0.05).
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allergic airway inflammation rats were cultured with or
without TSA for 24 hours. The level of LAT mRNA and
protein were significantly induced by TSA (Figure 4A-B-C).
To further determine whether TSA influences histone
modifications, ChIP assay was performed. TSA markedly
increased the level of acetylated histones H3 and H4 asso-
ciated with the LAT upstream region in lung T cells
(Figure 4D-E). However, there was no significant pattern in
the dimethylation level of histone H3K9. Therefore,
HDACs play important roles in repression of LAT tran-
scription and expression, depending on LAT site-specific
acetylation.
To rule out whether the cytokine profile can be
reversed by treating lung T cells with TSA in vitro, ex-
pression of IL-4 and IFN-γ in BALF and serum and lung
T cells were analyzed by ELISA. As expected, IL-4 ex-
pression was upregulated and IFN-γ expression was
downregulated both in BALF and serum in immunized
rats compared to non-immunized ones (Figure 5A-B).
Interestingly, there were significantly decreased IL-4
production and increased IFN-γ production in the lung
T cells from immunized rats cultured with TSA com-
pared to TSA negative sample (Figure 5A-B). Thus, TSA
can reverse lung Th1 or Th2 cytokine profiles in allergic
airway inflammation.
Discussion
In the present study, we show that LAT mRNA was
decreased in peripheral blood T cells from allergic asth-
matic patients, suggesting the involvement of LAT in T
cell differentiation in allergic asthma. Overexpression of
LAT by Nucleofection in peripheral blood T cells
enhanced Th1 differentiation. Conversely, in the absenceof LAT, Th2 differentiation was driven. Furthermore,
allergic airway inflammation rat model revealed that his-
tone hypoacetylation of LAT promoter could inhibit the
expression of LAT and enhanced Th2 differentiation in
lung tissue in vitro. In addition, TSA,a HDACs inhibitor,
enforced acetylation of histones H3 and H4 which
promoted LAT expression and inhibited Th2 cytokine
production.
During the past decades, the Th1/Th2 imbalance has
been well documented in the pathogenesis of allergic
asthma [23,24]. Even though several other T helper cells
have been reported recently, the Th2 cell is the main
effector involved in the development of allergic asthma
[25]. However, the initiation of T cell differentiation in
the disease is not well understood. LAT, a transmem-
brane adapter protein, has been reported to be necessary
for T cell development and function [5]. Experiments
using LAT-deficient mice indicate that T cells in theses
mice are hyperactivated and undergo a huge expansion,
causing a fatal lymphoproliferative autoimmune disease
[6,7]. A recent study also observed an abnormal pattern
of expression and localization of LAT in lipid rafts after
in vitro activation of lupus T cell [26]. In peripheral
blood T cell of allergic asthmatic patients, we detected
profoundly reduced expression of LAT mRNA, and Th2
cytokine production was conversely related to the ex-
pression of LAT. These results are consistent with re-
cent reports that mice homozygous for a single tyrosine
mutation in LAT develop a Th2 “autoimmune” lympho-
proliferative disorder with excessive amounts of Th2
cytokines [27]. In-vivo allergen-induced airway inflam-
mation study reported that overexpression of LAT pre-
vented the development of airway inflammation with
pronouncing reduction of inflammatory cells and IL-4 in
Figure 3 Histone hypoacetylation inhibits LAT transcription in lung T cells after OVA exposure. A) The mRNA expression of LAT was
determined by RT-PCR in lung T cells isolated from OVA-immunized rats. Non-immunized rats were used as control. The mRNA expression of LAT
was normalized to β-actin and shown as the relative content of LAT mRNA. B) and C) Immunoblot analysis of LAT expression in lung T cells
isolated from immunized or non-immunized rats. Data is shown as LAT/GAPDH ratio. D) and E) Western blots analysis of the protein level of
HDAC1, H3Ac, H4Ac and H3K9me2 in lung T cells isolated from immunized rats and non-immunized ones. GAPDH was used as a loading control.
Data is shown as relative percentage. F) and G) ChIP assays of histone acetylation and methylation status on LAT promoter in lung T cells isolated
from immunized rats and non-immunized ones. The data represents agarose gel electrophoretic separation of amplicons obtained after PCR
(a representative experiment from a series of three is shown). Input DNA served as positive internal control for sample integrity. Data is shown as
mean ± SD of triplicate samples. *p < 0.05; **p < 0.01; P-value were calculated from two or three independent experiments with consistent results.
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that LAT is involved in allergic asthma by regulating the
type-2 immune responses.
Single nucleotide polymorphisms (SNP), as the third
generation of heredity markers, are widely used to study
the mechanism of the susceptibility in human complex
diseases, and the design of individualized treatment
[29-31]. In the current study, we didn’t find the diver-
sity of SNP in promoter, external and inter from periph-
eral blood T cells from allergic asthmatic patients (datanot shown), suggesting that other factors may be involved
in regulating LAT expression.
Histones are capable of being post-translationally
modified by acetylation, methylation, ubiquitination or
phosphorylation, all of which have been implicated in
regulation of gene expression [32,33]. It was hypothesis
that histone modifications can regulate LAT expression.
As expected, it showed dramatically reduced histone H3
and H4 acetylation and significantly increased histone
H3K9 dimethylation on LAT promoter in lung T cells
Figure 4 TSA promotes LAT transcription and expression in lung T cells in OVA-immunized rats. Lung T cells isolated from OVA-
immunized rats were treated with or without TSA (2.5 ng/ml) for 24 h. A) The LAT mRNA level was determined by real-time PCR and normalized
to β-actin. B)and C) LAT protein was determined by Western Blot and normalized to the housekeeping gene GAPDH. D) and E) ChIP assays of
histone acetylation and methylation status on LAT promoter in lung T cells with or without TSA. The data represents agarose gel electrophoretic
separation of amplicons obtained after PCR (a representative experiment from a series of three is shown). Input DNA served as positive internal
control for sample integrity. Data is shown as mean ± SD, n = 10 (** p < 0.01).
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LAT promoter may be gene-specific in lung T cells of
allergic airway inflammation. Moreover, we found that the
expression of HDAC1 in lung T cells was decreased in asth-
matic rats, which is consistent with the report that the en-
dogenous HDAC activity plays a pivotal role in preventingFigure 5 TSA can reverse cytokine profiles in T cell differentiation in
challenge. The concentration of IL-4 (A) and IFN-γ (B) in the BAL fluid and
directly by ELISA. Lung T cells isolated from OVA-immunized rats were cult
after incubation with or without TSA (2.5 ng/ml).pre-established cytokine responses from deviating toward
excessive Th2-like immunity [34]. Our data indicates that
histone modifications may affect the development of type2
immune response by regulating LAT.
TSA is a reversible and specific HDAC inhibitor
that increases histone acetylation and deregulates genevitro. BAL fluid and serum were harvested 24 hours after the last
serum in OVA-immunized rats or non-immunized rats were measured
ured and IL-4 (A) and IFN-γ (B) in the supernatant were measured 24 h
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attenuates the development of allergic airway inflamma-
tion by decreasing expression of the Th2 cytokines, which
resulted from reduced T cell infiltration in the lung tissue
[35]. By treating lung T cells with or without TSA in vitro,
we observed that TSA markedly increased the level of his-
tones H3 and H4 acetylation on LAT promoter in lung T
cells. In addition, LAT gene transcription and protein
expression were both increased by TSA in lung T cells iso-
lated from allergic airway inflammation rats. Furthermore,
TSA has the ability to reverse cytokine profiles by inhibit-
ing Th2 cytokine production and enhancing Th1. The
above data argues that HDACs have a crucial role in
repression of the LAT expression in allergic airway
inflammation.
Conclusions
Thus, our study highlights the importance of LAT
expression in allergic asthma and suggests that histone
modification can influence LAT expression and regulate
allergic airway inflammation. Our findings have import-
ant implications for therapeutically targeting LAT in
allergic asthma.
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